Healthcare Services

Introduction Of Innovative Implantable Device Approved For Advanced Treatment Is Affecting The Direction Of The Liver Cirrhosis Market

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Size Of The Liver Cirrhosis Market In 2026 And How Much Will It Reach By 2030?

The liver cirrhosis market has experienced substantial growth in recent years. It is projected to expand from $1.99 billion in 2025 to $2.15 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.8%. This historical growth can be linked to factors such as chronic alcohol consumption patterns, prevalent hepatitis b and c infections, restricted early detection of liver damage, an increasing incidence of fatty liver disease, and a past scarcity of curative treatment options.

The liver cirrhosis market is anticipated to experience robust expansion over the coming years. This market is projected to reach $2.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. Factors driving this growth during the forecast period include the escalating prevalence of NASH and metabolic syndrome, heightened consciousness regarding liver well-being, wider availability of diagnostic tests, a surging need for sophisticated liver treatments, and augmented healthcare expenditure on long-term illnesses. Key developments expected during this timeframe encompass the escalating incidence of chronic liver conditions, an intensified emphasis on prompt diagnosis and disease tracking, a heightened requirement for sustained disease management strategies, the proliferation of supportive and symptomatic treatments, and an increased necessity for expert hepatology services.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

What Influential Factors Are Boosting The Liver Cirrhosis Market Demand?

The projected rise in alcohol intake is set to boost the expansion of the liver cirrhosis market moving forward. Alcohol consumption pertains to the ingestion of alcoholic beverages, typically quantified by volume and frequency. Individuals are increasingly consuming alcohol because it helps them alleviate daily stress, builds social connections in gatherings, and improves moments of relaxation, alongside widespread media promotion and enhanced accessibility in various settings. For patients with excessive alcohol consumption, liver cirrhosis treatment concentrates on managing liver damage through abstinence, medications, and supportive care, while also addressing alcohol dependence with counseling and rehabilitation. For instance, in December 2024, the Bureau of Labor Statistics, a US-based government agency, reported that in 2023, U.S. households spent an average of $294 on alcoholic beverages consumed at home and $343 on those consumed outside the home. Consequently, the increasing consumption of alcohol propels the liver cirrhosis market.

How Is The Liver Cirrhosis Market Distributed Across Key Segments?

The liver cirrhosis market covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis

2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments

3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users

Subsegments:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis

3) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis

4) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis

Which Trends Are Contributing To Changes In The Liver Cirrhosis Market?

Companies operating within the liver cirrhosis market are prioritizing advancements in therapeutic alternatives, including the creation of active implantable medical devices, to enhance patient outcomes and expand treatment capabilities. Active implantable medical devices are electronically powered implants engineered to monitor, support, or improve organ function internally. For example, in December 2024, Sequana Medical NV, a medical device company based in Belgium, secured U.S. FDA approval for its alfapump system, which is the first active implantable medical device in the U.S. for addressing recurrent or refractory ascites caused by liver cirrhosis. This groundbreaking technology offers an automated and continuous method for fluid management by transferring surplus abdominal fluid to the bladder, thereby significantly decreasing the need for invasive therapeutic paracentesis. The alfapump signifies a major progression in enhancing patient outcomes and improving quality of life, serving an addressable market of approximately 70,000 patients in the United States.

Who Are The Firms Contributing To The Liver Cirrhosis Market Ecosystem?

Major companies operating in the liver cirrhosis market are F Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, GE HealthCare Technologies Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, Koninklijke Philips N.V., Samsung Medison Co. Ltd., Mindray Medical International Limited, Boston Scientific Corporation, Olympus Corporation, Echosens SA, Hologic Inc., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Perspectum Diagnostics Ltd., Owlstone Medical Ltd.

Access The Complete Liver Cirrhosis Market Report:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

Which Region Accounts For The Highest Share Of The Liver Cirrhosis Market?

North America was the largest region in the liver cirrhosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Liver Cirrhosis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp

Browse Through More Reports Similar to the Global Liver Cirrhosis Market 2026, By The Business Research Company

Liver Health Supplements Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-health-supplements-global-market-report

Liver Cancer Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Hepatic Encephalopathy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatic-encephalopathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795